News Daily News Novel Aldosterone Synthase Inhibitor Drops BP: Top-line Phase II Results Todd Neale November 16, 2022
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022
News Conference News AHA 2022 Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study Michael O'Riordan November 07, 2022
News Conference News AHA 2022 In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE Todd Neale November 05, 2022
News Daily News Extreme BP-Lowering Harmful After Stroke Thrombectomy: ENCHANTED2/MT Todd Neale November 01, 2022
News Daily News STEMI Patients With In-Hospital Cardiac Arrest Bear Outsize Mortality Burden Caitlin E. Cox October 31, 2022
News Conference News TCT 2022 SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss Michael O'Riordan September 19, 2022
News Conference News TCT 2022 RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP Todd Neale September 18, 2022
News Conference News ESC 2022 Higher BP, Oxygen Targets No Help in Comatose OHCA Patients: BOX Caitlin E. Cox August 27, 2022
News Conference News ESC 2022 TIME of Antihypertensive Dose Doesn’t Matter for CV Protection Todd Neale August 26, 2022
News Daily News Salt Substitutes Could Have BP, CV Benefits Worldwide: Meta-analysis Yael L. Maxwell August 16, 2022
News Conference News EuroPCR 2022 Registry Data Hint at MACE Benefit With Renal Denervation Michael O'Riordan May 17, 2022
News Conference News ACC 2022 SPYRAL HTN-ON MED at 3 Years: Renal Denervation’s BP Impact Endures Todd Neale April 08, 2022
News Daily News Acetaminophen Raises BP, Just Like NSAIDs Do, in Patients With Hypertension Yael L. Maxwell February 09, 2022